XT
AIM

XTX Topco’s AIM ImmunoTech AIM Stock Holding History

XTX Topco’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,590
Closed -$12K – 4872
2026
Q1 		$12K Buy
+20,590
New +$20.9K ﹤0.01% 3648
2025
Q2 		– Sell
-836
Closed -$10.2K – 3412
2025
Q1 		$10.2K Buy
836
+343
+70% +$5.51K ﹤0.01% 2247
2024
Q4 		$9.74K Sell
493
-167
-25% -$3.89K ﹤0.01% 2152
2024
Q3 		$17.8K Buy
660
+515
+355% +$17.2K ﹤0.01% 1863
2024
Q2 		$5.41K Buy
145
+4
+3% +$170 ﹤0.01% 1742
2024
Q1 		$6.65K Buy
+141
New +$5.84K ﹤0.01% 1697
2021
Q3 		– Sell
-293
Closed -$63K – 1229
2021
Q2 		$63K Buy
+293
New +$62.8K 0.02% 712

Other funds holding AIM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco's AIM Position: Q2 2026 in Review

XTX Topco sold out of AIM ImmunoTech (AIM) in Q2 2026, closing a stake of 20,590 shares — an estimated $12K sold.

XTX Topco first reported a position in AIM in Q2 2021 and held it in 7 quarters. The position peaked at $63K in Q2 2021. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • XTX Topco reported no remaining AIM ImmunoTech position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 20,590 AIM ImmunoTech shares in Q2 2026, an estimated $12K.
  • XTX Topco first reported a position in AIM ImmunoTech in Q2 2021 and held it in 7 quarters.
  • XTX Topco's AIM ImmunoTech position peaked at $63K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.